Company Overview

PRIME exits and American Healthcare Capital are proud to exclusively represent a Medical Device Company that has an FDA-listed Class I medical device to improve the lives of the more than 3 million people suffering from opioid use disorder (OUD). Methadone is a proven and long-used medication to treat OUD. However, it is inconvenient and disruptive to patients’ lives because it must be dispensed in person daily from approved clinics (OTPs) to control misuse or diversion and ensure patients comply with dosing.

Our client’s device is a custom-designed, unique lockbox that holds 13 liquid doses of methadone and only allows patient access to one dose per day on a timed schedule. Patients using the device must visit the treatment center every two weeks instead of daily. It has cloud-enabled analytics that informs providers and care managers of usage and compliance. The device is protected with issued and pending patents and is manufactured in limited supply under contract.

The Company has also designed and is developing a second-generation device that will manage and control access to medications in pill or capsule form with high abuse potential, such as methylphenidate for ADHD.           

Financial Overview

The company launched its first product in late 2024 to a group of local OTP clinics, but due to manufacturing constraints, product supply is limited. Thus far, the company has been funded with government grants and has operated since 2021. Employees who are major equity owners are taking little to no salary. Design modifications are in place that will reduce manufacturing costs by over 60%.

There are over 3 million OUD patients in the US, and about 500 thousand of those are on methadone therapy. The device will be marketed and sold or leased to OTPs, who will then gain payments from patients directly, Medicare/Medicaid reimbursement, or Opioid Settlement funds. Assuming a 20% market penetration, the company projects $100 million in sustained sales revenue after five years with an EBITDA of $50 million.

Staff Overview

The company has five full-time employees and two contractors. Depending on the nature of the transaction, they could be interested in staying on.

Patents

The devices are protected by US patents, with issued and allowed claims covering the systems’ mechanical, electronic, and communications design and utilities.

Asking Price

The price is to be determined. The Company is open to considering a range of structures and formats, including an acquisition in cash or equity, investments, or partnerships